Bern, 4 October 2021 – On 26 May 2021, the Swiss medical technology industry was downgraded to «third country» status. How is the sector doing today? What are the short- and long-term consequences of the EU's political turmoil for the (to-date very successful) Swiss medtech industry? What are the most pressing problems? And how can they be solved? Swiss Medtech has invited industry representatives to meet in Bern on 19 October to discuss these questions. Take this opportunity to discuss them in person. To kick things off, we will be asking Thomas Cottier, Professor Emeritus of European and International Business Law, to explain the possible legal options. In addition, you can expect a varied programme including two plenary sessions, various panel discussions, networking opportunities, and six breakout sessions focusing on each of the crucial issues.
